Abstract
Cephalendra, indica ∅ (41% v/v alcoholic extract of the wild variety of Cephalendra indica Naud.), on regular administration in doses ranging from 25 μml to 75 μml/100 g of
body weight (gbw) by the oral or intraperitoneal (ip) route produced a significant
fall in blood sugar level in alloxan-induced diabetic rats. Biochemical studies showed
stabilization of blood sugar level in 70% of cases of fourteen to twenty days after
withdrawal of the drug. Histopathological studies revealed regeneration of pancreatic
β cells. The hypothesis is that the drug acts through the hypothalamo-hypophysial-pancreatic
axis, producing selective regeneration of β cells. The drug may indirectly release
inhibitory factors from hypothalamic neurons, inhibiting the secretion of growth hormone
and triggering insulin secretion from β cells. The therapeutic action of the drug
on pancreatic β cells and lack of acute and subacute toxicity may open up new prospects
in the treatment of diabetes mellitus.